FDA Approves Third COVID-19 Antibody Treatment for Emergency Use – Pulmonology Advisor
A third antibody treatment designed to keep high-risk COVID-19 patients from being hospitalized was approved for emergency use by the FDA.
Related Articles
A Quarter of Patients With Mild Asthma Don’t Receive Guideline-Directed Therapy
Researchers assessed whether clinicians are following the updated GINA and NHLBI mild asthma guidelines, which do not recommend SABA use.
Four-Month TB Treatment, HPMZ, Excludes Most Patients and Has High Dropout Rate
Researchers in the US assessed a 4-month tuberculosis treatment regimen of isoniazid, rifapentine, moxifloxacin, and pyrazinamide (HPMZ).
Oral Corticosteroids Slightly Reduce Severity/Length of Stay in Preschool Wheeze
Researchers evaluated how oral corticosteroids affected wheezing severity and hospital length of stay in preschool children with acute wheeze.
Post-COVID-19 Chronic Cough Is Unaffected by Inhaled Corticosteroids
Researchers examined the clinical characteristics and efficacy of inhaled corticosteroids in post COVID-19 chronic cough during the Omicron phase of the pandemic.
Diagnosis & Disease Info – Pulmonology Advisor
Viral pneumonia, a lung infection caused by a virus, is most commonly caused by influenza virus, RSV, and coronaviruses.
Inappropriate Pneumonia Diagnosis Common in Older and Mentally Impaired Patients
Researchers sought to describe factors associated with inappropriate diagnosis of community-acquired pneumonia in hospitalized patients.
Food Allergy/Asthma Risk Linked to Early Childhood Metabolomic Profiles
Researchers identified metabolites which are unique to and shared by children with food allergy and/or asthma, using birth cohort data from inner city children.
High Suspicion Crucial to Identifying Pediatric Egg-Induced Anaphylaxis
Investigators described the clinical characteristics, management, and outcomes of pediatric egg-induced anaphylaxis.
AIRQ Tool Heightens Awareness of Uncontrolled Asthma, Exacerbation Risk
Researchers evaluated how AIRQ compared with other asthma evaluation modalities in assessing asthma control and predicting exacerbation risk.
Online Resources for Inhaler Therapy Omit Important Information
Researchers evaluated the reliability and accuracy of online resources describing inhaler techniques, comparing online information with product profiles.